235 related articles for article (PubMed ID: 23582447)
1. Novel imino sugar α-glucosidase inhibitors as antiviral compounds.
Howe JD; Smith N; Lee MJ; Ardes-Guisot N; Vauzeilles B; Désiré J; Baron A; Blériot Y; Sollogoub M; Alonzi DS; Butters TD
Bioorg Med Chem; 2013 Aug; 21(16):4831-8. PubMed ID: 23582447
[TBL] [Abstract][Full Text] [Related]
2. Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus.
Durantel D; Branza-Nichita N; Carrouée-Durantel S; Butters TD; Dwek RA; Zitzmann N
J Virol; 2001 Oct; 75(19):8987-98. PubMed ID: 11533162
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of host ER glucosidase activity prevents Golgi processing of virion-associated bovine viral diarrhea virus E2 glycoproteins and reduces infectivity of secreted virions.
Jordan R; Nikolaeva OV; Wang L; Conyers B; Mehta A; Dwek RA; Block TM
Virology; 2002 Mar; 295(1):10-9. PubMed ID: 12033761
[TBL] [Abstract][Full Text] [Related]
4. Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents.
Zitzmann N; Mehta AS; Carrouée S; Butters TD; Platt FM; McCauley J; Blumberg BS; Dwek RA; Block TM
Proc Natl Acad Sci U S A; 1999 Oct; 96(21):11878-82. PubMed ID: 10518544
[TBL] [Abstract][Full Text] [Related]
5. Antiviral effect of N-butyldeoxynojirimycin against bovine viral diarrhea virus correlates with misfolding of E2 envelope proteins and impairment of their association into E1-E2 heterodimers.
Branza-Nichita N; Durantel D; Carrouée-Durantel S; Dwek RA; Zitzmann N
J Virol; 2001 Apr; 75(8):3527-36. PubMed ID: 11264342
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological characterisation of novel N-alkyl-deoxynojirimycin alpha-glucosidase inhibitors.
Rawlings AJ; Lomas H; Pilling AW; Lee MJ; Alonzi DS; Rountree JS; Jenkinson SF; Fleet GW; Dwek RA; Jones JH; Butters TD
Chembiochem; 2009 Apr; 10(6):1101-5. PubMed ID: 19294724
[TBL] [Abstract][Full Text] [Related]
7. Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors.
Chapel C; Garcia C; Bartosch B; Roingeard P; Zitzmann N; Cosset FL; Dubuisson J; Dwek RA; Trépo C; Zoulim F; Durantel D
J Gen Virol; 2007 Apr; 88(Pt 4):1133-1143. PubMed ID: 17374756
[TBL] [Abstract][Full Text] [Related]
8. Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity.
Lazar C; Durantel D; Macovei A; Zitzmann N; Zoulim F; Dwek RA; Branza-Nichita N
Antiviral Res; 2007 Oct; 76(1):30-7. PubMed ID: 17548120
[TBL] [Abstract][Full Text] [Related]
9. Strategy for Designing Selective Lysosomal Acid α-Glucosidase Inhibitors: Binding Orientation and Influence on Selectivity.
Kato A; Nakagome I; Hata M; Nash RJ; Fleet GWJ; Natori Y; Yoshimura Y; Adachi I; Hirono S
Molecules; 2020 Jun; 25(12):. PubMed ID: 32575625
[TBL] [Abstract][Full Text] [Related]
10. [Affect of deoxynojirimycin derivatives on hepatitis C virus morphogenesis].
Timokhova AV; Bakinovskiĭ LV; Zinin AI; Popenko VI; Ivanov AV; Rubtsov PM; Kochetkov SN; Belzhelarskaia SN
Mol Biol (Mosk); 2012; 46(4):644-53. PubMed ID: 23113354
[TBL] [Abstract][Full Text] [Related]
11. Imino sugars that are less toxic but more potent as antivirals, in vitro, compared with N-n-nonyl DNJ.
Mehta A; Ouzounov S; Jordan R; Simsek E; Lu X; Moriarty RM; Jacob G; Dwek RA; Block TM
Antivir Chem Chemother; 2002 Sep; 13(5):299-304. PubMed ID: 12630678
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of hepatitis B virus DNA replication by imino sugars without the inhibition of the DNA polymerase: therapeutic implications.
Mehta A; Carrouée S; Conyers B; Jordan R; Butters T; Dwek RA; Block TM
Hepatology; 2001 Jun; 33(6):1488-95. PubMed ID: 11391538
[TBL] [Abstract][Full Text] [Related]
13. Selection of the biological activity of DNJ neoglycoconjugates through click length variation of the side chain.
Ardes-Guisot N; Alonzi DS; Reinkensmeier G; Butters TD; Norez C; Becq F; Shimada Y; Nakagawa S; Kato A; Blériot Y; Sollogoub M; Vauzeilles B
Org Biomol Chem; 2011 Aug; 9(15):5373-88. PubMed ID: 21512716
[TBL] [Abstract][Full Text] [Related]
14. Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases.
Asano N; Nishida M; Kato A; Kizu H; Matsui K; Shimada Y; Itoh T; Baba M; Watson AA; Nash RJ; Lilley PM; Watkin DJ; Fleet GW
J Med Chem; 1998 Jul; 41(14):2565-71. PubMed ID: 9651160
[TBL] [Abstract][Full Text] [Related]
15. Binding parameters and thermodynamics of the interaction of imino sugars with a recombinant human acid alpha-glucosidase (alglucosidase alfa): insight into the complex formation mechanism.
Yoshimizu M; Tajima Y; Matsuzawa F; Aikawa S; Iwamoto K; Kobayashi T; Edmunds T; Fujishima K; Tsuji D; Itoh K; Ikekita M; Kawashima I; Sugawara K; Ohyanagi N; Suzuki T; Togawa T; Ohno K; Sakuraba H
Clin Chim Acta; 2008 May; 391(1-2):68-73. PubMed ID: 18328816
[TBL] [Abstract][Full Text] [Related]
16. Action of celgosivir (6 O-butanoyl castanospermine) against the pestivirus BVDV: implications for the treatment of hepatitis C.
Whitby K; Taylor D; Patel D; Ahmed P; Tyms AS
Antivir Chem Chemother; 2004 May; 15(3):141-51. PubMed ID: 15266896
[TBL] [Abstract][Full Text] [Related]
17. Natural iminosugar derivatives of 1-deoxynojirimycin inhibit glycosylation of hepatitis viral envelope proteins.
Jacob JR; Mansfield K; You JE; Tennant BC; Kim YH
J Microbiol; 2007 Oct; 45(5):431-40. PubMed ID: 17978803
[TBL] [Abstract][Full Text] [Related]
18. CuAAC click chemistry with N-propargyl 1,5-dideoxy-1,5-imino-D-gulitol and N-propargyl 1,6-dideoxy-1,6-imino-D-mannitol provides access to triazole-linked piperidine and azepane pseudo-disaccharide iminosugars displaying glycosidase inhibitory properties.
Zamoner LO; Aragão-Leoneti V; Mantoani SP; Rugen MD; Nepogodiev SA; Field RA; Carvalho I
Carbohydr Res; 2016 Jun; 429():29-37. PubMed ID: 27160849
[TBL] [Abstract][Full Text] [Related]
19. Synthetic 1-deoxynojirimycin N-substituted peptides offer prolonged disruption to N-linked glycan processing.
Aguilar AL; Escribano J; Wentworth P; Butters TD
ChemMedChem; 2014 Dec; 9(12):2809-13. PubMed ID: 25352425
[TBL] [Abstract][Full Text] [Related]
20. The combination of interferon alpha-2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: implications for hepatitis C virus (HCV) therapy.
Ouzounov S; Mehta A; Dwek RA; Block TM; Jordan R
Antiviral Res; 2002 Sep; 55(3):425-35. PubMed ID: 12206880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
